Zai Lab Limited (ZLAB)
(Delayed Data from NSDQ)
$16.25 USD
0.00 (0.00%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $16.27 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Zai Lab Limited Unsponsored ADR (ZLAB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$46.33 | $66.00 | $25.00 | 185.11% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Zai Lab Limited Unsponsored ADR comes to $46.33. The forecasts range from a low of $25.00 to a high of $66.00. The average price target represents an increase of 185.11% from the last closing price of $16.25.
Analyst Price Targets (6 )
Broker Rating
Zai Lab Limited Unsponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, seven are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ZLAB.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
6/25/2024 | Cantor Fitzgerald & Co | Louise Chen | Strong Buy | Strong Buy |
2/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 7 |
Average Target Price | $46.33 |
LT Growth Rate | 26.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | -0.71 |